Clinical research

Genomics project to see £160m industry investment as part of disease detection programme

Businesses and charities are expected to invest up to £160m to help support research into the early diagnosis, prevention and treatment of diseases as part of the Accelerating Detection of Disease programme.…

Peter Hylands (1946–2019)

As the first pharmaceutical scientist member of the Royal Pharmaceutical Society, Peter Hylands’ respected and varied career specialised in natural products research.…

How to understand and interpret clinical data

This resource, part of the acute pain learning series, has been developed to help pharmacists understand the quality of evidence from clinical data to inform the advice they give to patients.…

Supported content

Immunotherapy delays type 1 diabetes mellitus in high-risk individuals

Certain individuals at high risk of developing type 1 diabetes mellitis can delay progression to clinical disease by two years or more with a two-week course of teplizumab, according to results of a phase II study.…

Esketamine nasal spray effective for rapid improvement of depressive symptoms

The ketamine-related nasal spray esketamine is effective at relieving the symptoms of treatment-resistant depression, a phase III study has shown.…

Daily isradipine is ineffective at slowing Parkinson’s disease

The blood pressure therapy isradipine does not slow disease progression in people with early-stage Parkinson’s disease, findings presented at the American Academy of Neurology Annual Meeting have shown.…

Aspirin safe to take after stroke caused by bleeding in the brain, study finds

Antiplatelet medicines, such as aspirin, appear to be safe and possibly beneficial for patients who have suffered an intracerebral haemorrhagic stroke, results from a clinical trial published in The Lancet suggest.…

Fish oils for cardiovascular disease: a turning point?

The use of fish oils to improve cardiovascular health has been in and out of favour for decades, but positive results from a recent trial of Amarin’s Vascepa have created quite a stir — particularly as they come after a set of negative findings in 2018.…

Cannabis trade body will also focus on clinical trials

The Centre for Medicinal Cannabis has announced plans to extend its remit to focus on clinical trials.…

Most popular research briefings of 2018

In 2018, our most popular research briefings covered new areas of research that have been particularly topical this year — including medical cannabis, new antibiotics and e-cigarettes — as well as areas that have long been of interest to pharmacists, such as pain management and…